CVS Health (CVS) Reports In-Line Q4 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to CVS Health (CVS) Reports In-Line Q4 EPS

FBR Still Impressed with CVS Health (CVS) Following Inline Q4 Results; Affirms at 'Outperform'

February 9, 2016 2:34 PM EST

FBR & Co. reaffirms its Outperform rating and $120 price target on CVS Health (NYSE: CVS) following the retail pharmacy giant's Q4 report earlier Tuesday.

Analyst Steven Halper noted that revenue increased 11 percent and was inline with expectations, as was the company's quarterly... More

Leerink Partners Continues to View CVS Health (CVS) as a High Quality Stock - Reiterates Outperform

February 9, 2016 2:07 PM EST

Leerink Partners reiterated an Outperform rating on CVS Health (NYSE: CVS), and cut the price target to $110.00 (from $125.00), following the company's 4Q earnings report and conference call. On the call management highlighted that total specialty revenue grew +32% y/y, total gross PBM wins... More